“Genomic Epidemiology and Evolution of Drug Resistance in Candida auris” — Brown University’s Christina Cuomo, PhD
Please join us for a seminar from Brown University’s Christina Cuomo, PhD, a Professor of Molecular Microbiology & Immunology who works to identify mechanisms of virulence and drug resistance that can be used to guide and refine treatment decisions. Dr.
“The Intersection of Racism, Antimicrobial Resistance, and Vaccine Equity” — UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences’ Jacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP
We are excited to announce that Jacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP will present on “The Intersection of Racism, Antimicrobial Resistance, and Vaccine Equity” for a Black History Month seminar sponsored jointly by Micro DEI, the Levy CIMAR, and the Tufts
Clinical and Basic Science Approaches to AMR: “Uncovering Antibiotic Allergy in Massachusetts Long-Term Care Facilities: Reporting Patterns and Impact on Antibiotic Prescribing” – Kap Sum Foong, MD & “Applying the Mouse Pneumonia Model of Acinetobacter baumannii for the Evolution and Characterization of Colistin-Selected Mutants” – Tufts MERGE-ID PhD Candidate Juan Hernandez-Bird
Our December 14th Levy CIMAR Science Seminar will explore antimicrobial resistance from both clinical and basic science perspectives. We will hear from two speakers this month: Tufts Medical Center’s Kap Sum Foong, MD, an Attending Physician with expertise in antimicrobial stewardship
Clinical and Basic Science Approaches to Phage: “Bringing Phage to Bedside: Implementing a Phage Clinical Trial” – Brian Chow, MD & “Looking for Validation: Assessing ICP1 Mutant Fitness After Tn-seq” – Tufts Molecular Microbiology PhD Candidate Elizabeth Tan
Please join us for our November Levy CIMAR Science Seminar, which will dive into recent bacteriophage work from both the clinical and basic science perspectives. We will hear from two speakers this month: CIMAR’s own Brian Chow, MD, an Attending
Please join us for this month’s Levy CIMAR Science Talk from our own Shira Doron, MD, who among her many titles is Chief Infection Control Officer for Tufts Medicine where she oversees Infection Control and Antimicrobial Stewardship. She is also
Discovery and Development of Novel Antimalarials and Their Use as Chemical Tools to Discover New Biology of the Malaria Parasite – WEHI’s Prof. Alan F. Cowman
We are excited to announce our first seminar speaker for the 2023-2024 academic year, Professor Alan F. Cowman, who among his many roles is acting Director of Australia's Walter and Eliza Hall Institute of Medical Research (WEHI). An internationally acclaimed expert
Transcriptional Profiling for Infectious Disease Diagnostics and Discovery – Massachusetts General Hospital’s Roby Bhattacharyya, MD, PhD
We are pleased to welcome Massachusetts General Hospital’s Roby Bhattacharyya, MD, PhD, to present for our May 25th Levy CIMAR Science Lunch, our last seminar of the ’22-’23 season! Dr. Bhattacharyya is an Assistant Professor in the Infectious Diseases Division at
Metabolic Modeling Predicts Unique Drug Targets in the Lyme Disease Pathogen Borrelia burgdorferi – Tufts University School of Medicine’s Peter Gwynne, PhD
Please join us for our February Levy CIMAR Science Lunch presented by Lyme disease expert Peter Gwynne, PhD, a research assistant professor at the Tufts University School of Medicine and Director for Translational Research at the Tufts University Lyme Disease
One Health Approach to Antimicrobial Stewardship in Companion Animals – Tufts Vet School’s Claire Fellman, D.V.M., Ph.D., DACVIM (SA), DACVCP
Please join us for the first Levy CIMAR Science Seminar of 2023! We will hear from our own Claire Fellman, DVM, PhD, an Assistant Professor in the Department of Clinical Sciences at the Tufts Cummings School of Veterinary Medicine on
Engineering Phages as Novel Antimicrobials Targeting Gram-Negative Pathogens – Massachusetts General Hospital’s Bryan Lenneman, Ph.D.
Please join us in person or on Zoom for the March 2023 Levy CIMAR Science Lunch seminar from Bryan Lenneman, Ph.D., a Research Fellow at Massachusetts General Hospital. Dr. Lenneman will present on "Engineering Phages as Novel Antimicrobials Targeting Gram-Negative Pathogens." Dr.